Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
Settings
CPRX [NASD]
Catalyst Pharmaceutical Partners Inc.
Index- P/E- EPS (ttm)-0.28 Insider Own6.10% Shs Outstand65.49M Perf Week-13.51%
Market Cap125.74M Forward P/E- EPS next Y-0.23 Insider Trans2.65% Shs Float52.85M Perf Month-10.28%
Income-12.20M PEG- EPS next Q-0.06 Inst Own14.60% Short Float11.88% Perf Quarter-4.48%
Sales- P/S- EPS this Y-92.90% Inst Trans-53.12% Short Ratio6.27 Perf Half Y-27.55%
Book/sh0.39 P/B4.92 EPS next Y4.20% ROA-59.70% Target Price4.69 Perf Year300.00%
Cash/sh0.36 P/C5.31 EPS next 5Y- ROE-73.10% 52W Range0.46 - 3.65 Perf YTD-1.54%
Dividend- P/FCF- EPS past 5Y19.70% ROI- 52W High-47.40% Beta0.60
Dividend %- Quick Ratio12.00 Sales past 5Y- Gross Margin- 52W Low317.39% ATR0.19
Employees7 Current Ratio12.00 Sales Q/Q- Oper. Margin- RSI (14)40.69 Volatility10.51% 9.09%
OptionableYes Debt/Eq0.00 EPS Q/Q- Profit Margin- Rel Volume1.71 Prev Close1.96
ShortableYes LT Debt/Eq0.00 EarningsNov 11 Payout- Avg Volume1.00M Price1.92
Recom2.00 SMA20-14.72% SMA50-10.15% SMA200-0.91% Volume1,708,356 Change-2.04%
21-Oct-13Reiterated Aegis Capital Buy $4 → $5.50
24-Sep-13Initiated Maxim Group Buy $4
06-Sep-13Reiterated Aegis Capital Buy $3.50 → $4
18-Apr-13Initiated Aegis Capital Buy $2.50
27-Aug-12Upgrade Rodman & Renshaw Mkt Perform → Mkt Outperform $3.70
01-Oct-09Upgrade Merriman Sell → Neutral
29-May-09Downgrade Merriman Curhan Ford Buy → Sell
29-May-09Downgrade Hapoalim Neutral → Underperform
15-Dec-08Initiated Merriman Curhan Ford Buy
28-Nov-07Initiated Rodman & Renshaw Mkt Outperform $9
31-Jan-07Initiated Stifel Nicolaus Buy $9
05-Jan-07Initiated First Albany Buy $10
09-Apr-14 02:58PM  A Small-Cap Biotech Stock on the Verge of a Breakout at TheStreet
08-Apr-14 10:58AM  CATALYST PHARMACEUTICAL PARTNERS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online +7.77%
10:30AM  Catalyst Pharmaceutical Partners, Inc. Announces Closing of Previously Announced Public Offering GlobeNewswire
04-Apr-14 02:01AM  Catalyst Pharmaceutical Partners Inc. (CPRX) Jumps: Stock Up 8.6% Zacks -5.83%
03-Apr-14 04:32PM  CATALYST PHARMACEUTICAL PARTNERS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Stat EDGAR Online +8.60%
09:00AM  Catalyst Pharmaceutical Partners, Inc. Prices Public Offering of Common Stock GlobeNewswire
02-Apr-14 04:05PM  Catalyst Pharmaceutical files to sell common stock, no amount given at theflyonthewall.com
04:04PM  Catalyst Pharmaceutical Partners, Inc. Announces Commencement of Public Offering of Common Stock GlobeNewswire
01-Apr-14 12:59PM  [$$] 7 Stock Picks From an Insider Trading Guru at Barrons.com
08:19AM  CATALYST PHARMACEUTICAL PARTNERS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
08:03AM  Catalyst Announces Completion of Enrollment in Pivotal Phase 3 Trial of Firdapse(TM) in Patients With Lambert-Eaton Myasthenic Syndrome GlobeNewswire
05:56AM  [$$] 7 Stock Picks From an Insider Trading Guru at Barrons.com
28-Mar-14 08:36AM  CATALYST PHARMACEUTICAL PARTNERS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
08:06AM  Catalyst Pharmaceutical names Barrett McGrath as Chief Commercial Officer theflyonthewall.com
08:03AM  Catalyst Pharmaceutical Partners Expands Executive Leadership Team to Support the Commercialization of Firdapse(TM) GlobeNewswire
26-Mar-14 05:30PM  Good News for Catalyst Pharma Zacks
25-Mar-14 04:51PM  CATALYST PHARMACEUTICAL PARTNERS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
08:03AM  Catalyst Pharmaceutical Partners Announces Recommendation of Data Monitoring Committee to Continue Pivotal Phase 3 Clinical Trial for Firdapse(TM) GlobeNewswire
22-Mar-14 01:04PM  CATALYST PHARMACEUTICAL PARTNERS, INC. Financials EDGAR Online Financials
21-Mar-14 06:11AM  Catalyst Pharmaceutical Partners (CPRX) in Focus: Stock Moves 6.2% Higher Zacks
20-Mar-14 05:17PM  CATALYST PHARMACEUTICAL PARTNERS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online +6.22%
08:20AM  Narrower-than-Expected Loss at Catalyst Pharma Zacks
19-Mar-14 08:03AM  Catalyst Pharmaceutical Partners Announces Fourth Quarter and Year-End 2013 Financial Results and Provides Corporate Update GlobeNewswire
06:02AM  CATALYST PHARMACEUTICAL PARTNERS, INC. Files SEC form 10-K, Annual Report EDGAR Online
06-Mar-14 08:03AM  Catalyst Pharmaceutical Partners to Present at the 26th Annual ROTH Conference GlobeNewswire
04-Mar-14 05:03PM  CATALYST PHARMACEUTICAL PARTNERS, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Regulation FD D EDGAR Online
28-Feb-14 08:03AM  Catalyst Pharmaceutical Partners Observes Rare Disease Day Today GlobeNewswire
20-Feb-14 04:34PM  CATALYST PHARMACEUTICAL PARTNERS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Stat EDGAR Online +11.68%
06-Feb-14 08:03AM  Catalyst Pharmaceutical Partners to Present at 16th Annual BIO CEO & Investor Conference GlobeNewswire
08-Jan-14 08:24AM  CATALYST PHARMACEUTICAL PARTNERS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online +5.94%
08:24AM  CATALYST PHARMACEUTICAL PARTNERS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
08:03AM  Catalyst Pharmaceutical Partners Reports Positive Cardiac Safety Results of Its Phase 3 Product, Firdapse Tablets GlobeNewswire
08:03AM  Catalyst Pharmaceutical Partners Reports Positive Cardiac Safety Results of Its Phase 3 Product, Firdapse Tablets
07-Jan-14 08:14AM  Catalyst Pharmaceutical announces dismissal of stockholder class action lawsuit at theflyonthewall.com
08:14AM  Catalyst Pharmaceutical announces dismissal of stockholder class action lawsuit
08:03AM  Catalyst Pharmaceutical Partners Reports Dismissal of Stockholder Class Action Lawsuit GlobeNewswire
08:03AM  Catalyst Pharmaceutical Partners Reports Dismissal of Stockholder Class Action Lawsuit
06-Jan-14 08:15AM  Catalyst reports successful completion of Type B therapy meeting with FDA at theflyonthewall.com
08:15AM  Catalyst reports successful completion of Type B therapy meeting with FDA
08:03AM  Catalyst Pharmaceutical Partners Reports Successful Completion of Type B Breakthrough Therapy Meeting With FDA on Firdapse Tablets Development Program GlobeNewswire
08:03AM  Catalyst Pharmaceutical Partners Reports Successful Completion of Type B Breakthrough Therapy Meeting With FDA on Firdapse Tablets Development Program
20-Dec-13 09:30PM  Glancy Binkow & Goldberg LLP Announces a December 24, 2013 Lead Plaintiff Deadline in the Class Action Lawsuit Against Catalyst Pharmaceutical Partners, Inc. -- CPRX GlobeNewswire
09:30PM  Glancy Binkow & Goldberg LLP Announces a December 24, 2013 Lead Plaintiff Deadline in the Class Action Lawsuit Against Catalyst Pharmaceutical Partners, Inc. -- CPRX
17-Dec-13 06:50PM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of Class Action Against Catalyst Pharmaceutical Partners, Inc. and Its Board of Directors and a Lead Plaintiff Deadline of December 24, 2013 Business Wire
06:50PM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of Class Action Against Catalyst Pharmaceutical Partners, Inc. and Its Board of Directors and a Lead Plaintiff Deadline of December 24, 2013
03:14AM  EQUITY ALERT: Rosen Law Firm Reminds Catalyst Pharmaceutical Partners Investors of Important December 24, 2013 Deadline in Class Action -- CPRX GlobeNewswire
03:14AM  EQUITY ALERT: Rosen Law Firm Reminds Catalyst Pharmaceutical Partners Investors of Important December 24, 2013 Deadline in Class Action -- CPRX
12-Dec-13 12:27PM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of Class Action Against Catalyst Pharmaceutical Partners, Inc. and Its Board of Directors and a Lead Plaintiff Deadline of December 24, 2013 -- CPRX Marketwired
12:27PM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of Class Action Against Catalyst Pharmaceutical Partners, Inc. and Its Board of Directors and a Lead Plaintiff Deadline of December 24, 2013 -- CPRX Marketwire
12:27PM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of Class Action Against Catalyst Pharmaceutical Partners, Inc. and Its Board of Directors and a Lead Plaintiff Deadline of December 24, 2013 -- CPRX
10-Dec-13 09:32PM  Law Offices of Howard G. Smith Announces Lead Plaintiff Deadline in the Class Action Lawsuit Against Catalyst Pharmaceutical Partners, Inc. Business Wire
09-Dec-13 04:21PM  DEADLINE ALERT: Rigrodsky & Long, P.A. Reminds Shareholders of Catalyst Pharmaceutical Partners, Inc. of Upcoming Deadline Business Wire -6.22%
06-Dec-13 09:32PM  Law Offices of Howard G. Smith Announces Class Action Lawsuit Against Catalyst Pharmaceutical Partners, Inc. Business Wire
05-Dec-13 02:12PM  5 Stocks Under $10 Set to Soar at TheStreet
04-Dec-13 07:00AM  4 Biotech Stocks Under $10 to Watch at TheStreet +5.35%
02-Dec-13 04:29PM  SHAREHOLDER ALERT: LEVI & KORSINSKY, LLP Reminds Investors of Class Action Against Catalyst Pharmaceutical Partners, Inc. and Its Board of Directors and a Lead Plaintiff Deadline of December 24, 2013 -- CPRX GlobeNewswire +8.72%
27-Nov-13 09:32PM  Law Offices of Howard G. Smith Announces Investigation on Behalf of Investors of Catalyst Pharmaceutical Partners, Inc. Business Wire
22-Nov-13 06:30PM  Pomerantz Law Firm Has Filed a Class Action Against Catalyst Pharmaceutical Partners, Inc. and Certain Officers -- CPRX GlobeNewswire
19-Nov-13 01:04PM  CATALYST PHARMACEUTICAL PARTNERS, INC. Financials EDGAR Online Financials -8.56%
18-Nov-13 06:19PM  Glancy Binkow & Goldberg Announces Lead Plaintiff Deadline In The Class Action Lawsuit Against Catalyst Pharmaceutical Partners, Inc. Business Wire +16.87%
05:38PM  4 Healthcare Stock Stories Ready for a Week of Investment Wellness at Wall St. Cheat Sheet
05:20PM  CATALYST PHARMACEUTICAL PARTNERS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
08:03AM  InPlay: Catalyst Pharma announces publication of preclinical proof-of-principle of CPP-115 efficacy in suppressing infantile spasms in epilepsia; CPP-115 suppresses spasms in the multiple-hit model of IS; Phase I multiple-ascending dose stu Briefing.com
08:03AM  Catalyst Pharmaceutical Partners Announces Publication of Preclinical Proof-of-Principle of CPP-115 Efficacy in Suppressing Infantile Spasms in Epilepsia GlobeNewswire
14-Nov-13 08:14AM  CATALYST PHARMACEUTICAL PARTNERS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online +6.82%
08:03AM  Catalyst Pharmaceutical Partners Announces Third Quarter 2013 Financial Results GlobeNewswire
13-Nov-13 04:31PM  CATALYST PHARMACEUTICAL PARTNERS, INC. Files SEC form 10-Q, Quarterly Report EDGAR Online -8.33%
12-Nov-13 07:15PM  Glancy Binkow & Goldberg LLP Announces Class Action Lawsuit Against Catalyst Pharmaceutical Partners, Inc. Business Wire -5.26%
06:25PM  Attention Catalyst Investors: Catalyst Pharmaceutical Partners Misled Investors According to a Newly Filed Class Action PR Newswire
07-Nov-13 08:44AM  Zacks #1 Rank Additions for Thursday Zacks
04-Nov-13 07:05AM  6 Charts Explain An Ugly October for Biotech Stocks at TheStreet +5.23%
31-Oct-13 05:00PM  Federman & Sherwood Announces Filing of Securities Class Action Lawsuit Against Catalyst Pharmaceutical Partners, Inc. (NASDAQ: CPRX) Marketwired -6.36%
30-Oct-13 03:05PM  Catalyst Pharmaceutical Announces Social Media Presence GlobeNewswire
29-Oct-13 05:04PM  CATALYST PHARMACEUTICAL PARTNERS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
04:05PM  Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses in Excess of $100,000 Investing in Catalyst Pharmaceutical Partners, Inc. to Contact the Firm Marketwired
03:49PM  SHAREHOLDER ALERT: Brower Piven Encourages Investors With More Than $100,000 in Losses From Investment in Catalyst Pharmaceutical Partners, Inc. to Contact Brower Piven Before the December 24, 2013 Lead Plaintiff Deadline -- CPRX GlobeNewswire
08:11AM  InPlay: Catalyst Pharma updates on Its development activities for Firdapse; Catalyst expects that it will report top-line results from the double-blind portion of this Phase 3 trial during the second quarter of 2014 Briefing.com
08:03AM  Catalyst Pharmaceutical Updates on Its Development Activities for Firdapse(TM) GlobeNewswire
28-Oct-13 04:58PM  Rigrodsky & Long, P.A. Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Catalyst Pharmaceutical Partners, Inc. Business Wire
02:00PM  Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Announces that a Securities Class Action has been Filed Against Catalyst Pharmaceutical Partners Inc. PR Newswire
12:23PM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Class Action Against Catalyst Pharmaceutical Partners, Inc. and Its Board of Directors and a Lead Plaintiff Deadline of December 24, 2013 -- CPRX GlobeNewswire
25-Oct-13 06:51PM  The Rosen Law Firm Files Securities Fraud Class Action Against Catalyst Pharmaceutical Partners, Inc. CPRX Business Wire
05:20PM  CATALYST PHARMACEUTICAL PARTNERS, INC. Files SEC form 8-K/A, Submission of Matters to a Vote of Security Holders EDGAR Online
06:00AM  Biotech Stock Mailbag: Vanda, Onconova, Catalyst Pharma, Sarepta at TheStreet
23-Oct-13 09:37AM  Catalyst Pharmaceutical Partners President Buys 50K Shares and 4 Insider Buys to Note at Wall St. Cheat Sheet +10.44%
22-Oct-13 10:43AM  Catalyst Pharma Profiteering Assailed by LEMS Patients, Doctors at TheStreet +19.74%
08:23AM  Catalyst Pharmaceutical Partners, Inc. Enters Oversold Territory Zacks
21-Oct-13 11:55AM  The Rosen Law Firm Announces Investigation of Securities Claims Against Catalyst Pharmaceutical Partners, Inc. CPRX Business Wire -20.00%
11:01AM  Catalyst Pharmaceuticals And Their Business Plan at Seeking Alpha
08:14AM  Catalyst Pharmaceuticals: Recent Sell-Off Presents Buying Opportunity at Seeking Alpha
18-Oct-13 04:18PM  Shareholder Rights Law Firm Johnson & Weaver, LLP Announces Investigation of Catalyst Pharmaceutical Partners, Inc. Business Wire -27.20%
08:29AM  Catalyst Pharma: Orphan Drug Poseur, Profiteer at TheStreet
16-Oct-13 04:30PM  Good News for Catalyst Pharma's Pipeline Zacks
15-Oct-13 05:25PM  CATALYST PHARMACEUTICAL PARTNERS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
11:50AM  InPlay: Catalyst Pharma announces recommendation of Data Monitoring Committee to continue pivotal Phase 3 clinical trial for Firdapse Briefing.com
11:50AM  Catalyst Pharmaceutical Partners Announces Recommendation of Data Monitoring Committee to Continue Pivotal Phase lll Clinical Trial for Firdapse(TM) GlobeNewswire
08-Oct-13 08:55AM  Catalyst Pharma mentioned positively by Seeking Alpha contributor at theflyonthewall.com
04:14AM  Strong Comps Indicate Catalyst Pharmaceutical Partners Outstanding Value Proposition at Seeking Alpha
04-Oct-13 11:15AM  Catalyst Pharmaceutical Partners to Present at 12th Annual BIO Investor Forum GlobeNewswire
25-Sep-13 08:03AM  Catalyst Pharmaceutical Partners to Present at Aegis Capital 2013 Healthcare Conference GlobeNewswire
Catalyst Pharmaceutical Partners, Inc. operates as development-stage specialty pharmaceutical company. The company focuses on the development and commercialization of novel prescription drugs targeting rare (orphan) neuromuscular and neurological diseases and disorders. Its principal product candidate include Firdapse, a proprietary form of amifampridine phosphate, which is in Phase III clinical trial for the treatment of Lambert-Eaton Myasthenic Syndrome. The company also develops CPP-115, a vigabatrin analog to treat infantile spasms and epilepsy, as well as other neurological conditions associated with reduced GABAergic signaling, such as post-traumatic stress disorder and Tourette syndrome. Catalyst Pharmaceutical Partners, Inc. has strategic collaboration agreement with BioMarin. The company was founded in 2002 and is based in Coral Gables, Florida.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
MCENANY PATRICK JPresident and CEOFeb 07Buy1.8225,00045,5003,631,247Feb 07 02:04 PM
O'Keeffe Charles BDirectorFeb 05Buy1.8110,00018,099177,126Feb 06 04:08 PM
Tierney David SDirectorOct 23Buy2.038,00016,240213,401Oct 25 04:16 PM
MCENANY PATRICK JPresident and CEOOct 21Buy1.5950,00079,7303,606,247Oct 21 05:04 PM
O'Keeffe Charles BDirectorOct 21Buy1.8410,00018,392167,126Oct 21 05:03 PM